Comparison Overview

Carelon Research

VS

ALS Investiga

Carelon Research

123 Justison Street, Wilmington, DE, 19801, US
Last Update: 2025-03-04 (UTC)

Strong

Carelon Research is the trusted partner for healthcare research. As a subsidiary of Elevance Health, one of the nation’s largest health insurers, we work with life sciences companies, government agencies, and academic research leaders to solve healthcare challenges with a powerful combination of expertise, data, and relationships. As we uncover and apply insights to drugs, devices, and programs, together we make healthcare work for patients.

NAICS: 5417
NAICS Definition: Scientific Research and Development Services
Employees: 0
Subsidiaries: 22
12-month incidents
0
Known data breaches
5
Attack type number
3

ALS Investiga

Avenida Dr. Romeu Tórtima, 452 Campinas, São Paulo 13084-791, BR
Last Update: 2025-03-16 (UTC)

Excellent

Formada por um grupo de empresas especializadas na avaliação de produtos, que abrange as diversas etapas do seu desenvolvimento, desde a concepção até seu lançamento. Desde 1993, atuando no mercado nacional e internacional, atende clientes em diferentes países nas áreas de cosméticos, higiene pessoal, perfumaria, farmacêutica, OTC, household, produtos alimentícios, bebidas, tintas ou quaisquer outras áreas que ofereçam produtos para o uso humano. Show more Show less

NAICS: 541
NAICS Definition:
Employees: 10,001+
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/healthcore-inc..jpeg
Carelon Research
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/grupo-investiga.jpeg
ALS Investiga
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
Compliance Summary
Carelon Research
100%
Compliance Rate
0/4 Standards Verified
ALS Investiga
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Research Services Industry Average (This Year)

No incidents recorded for Carelon Research in 2025.

Incidents vs Research Services Industry Average (This Year)

No incidents recorded for ALS Investiga in 2025.

Incident History — Carelon Research (X = Date, Y = Severity)

Carelon Research cyber incidents detection timeline including parent company and subsidiaries

Incident History — ALS Investiga (X = Date, Y = Severity)

ALS Investiga cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/healthcore-inc..jpeg
Carelon Research
Incidents

Date Detected: 10/2022
Type:Breach
Blog: Blog

Date Detected: 10/2021
Type:Breach
Attack Vector: Theft
Blog: Blog

Date Detected: 8/2021
Type:Breach
Attack Vector: Physical Break-In (Vendor Office)
Blog: Blog
https://images.rankiteo.com/companyimages/grupo-investiga.jpeg
ALS Investiga
Incidents

No Incident

FAQ

ALS Investiga company company demonstrates a stronger AI risk posture compared to Carelon Research company company, reflecting its advanced AI governance and monitoring frameworks.

Carelon Research company has historically faced a number of disclosed cyber incidents, whereas ALS Investiga company has not reported any.

In the current year, ALS Investiga company and Carelon Research company have not reported any cyber incidents.

Carelon Research company has confirmed experiencing a ransomware attack, while ALS Investiga company has not reported such incidents publicly.

Carelon Research company has disclosed at least one data breach, while the other ALS Investiga company has not reported such incidents publicly.

Carelon Research company has reported targeted cyberattacks, while ALS Investiga company has not reported such incidents publicly.

Neither Carelon Research company nor ALS Investiga company has reported experiencing or disclosing vulnerabilities publicly.

Carelon Research company has more subsidiaries worldwide compared to ALS Investiga company.

Neither Carelon Research company nor ALS Investiga company has publicly disclosed the exact number of their employees.

Latest Global CVEs (Not Company-Specific)

Description

A weakness has been identified in bftpd up to 6.2. Impacted is the function expand_groups of the file options.c of the component Configuration File Handler. Executing manipulation can lead to heap-based buffer overflow. It is possible to launch the attack on the local host. Attacks of this nature are highly complex. The exploitability is considered difficult. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 3.5
Severity: HIGH
AV:L/AC:H/Au:S/C:P/I:P/A:P
cvss3
Base: 4.5
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 2.0
Severity: HIGH
CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in LogicalDOC Community Edition up to 9.2.1. This issue affects some unknown processing of the file /frontend.jsp of the component Add Contact Page. Performing manipulation of the argument First Name/Last Name/Company/Address/Phone/Mobile results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
cvss3
Base: 3.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in toeverything AFFiNE up to 0.24.1. This vulnerability affects unknown code of the component Avatar Upload Image Endpoint. Such manipulation leads to cross site scripting. The attack may be launched remotely. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
cvss3
Base: 3.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in givanz Vvveb up to 1.0.7.3. This affects the function Import of the file admin/controller/tools/import.php of the component Raw SQL Handler. This manipulation causes sql injection. The attack may be initiated remotely. The exploit has been publicly disclosed and may be utilized. Patch name: 52204b4a106b2fb02d16eee06a88a1f2697f9b35. It is recommended to apply a patch to fix this issue.

Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability has been found in 70mai X200 up to 20251010. Affected by this vulnerability is an unknown functionality of the component HTTP Web Server. The manipulation leads to use of default credentials. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X